RxDoctor Payments Data

Ashley Salter, NP

Nurse Practitioner · Casa Grande, AZNPI 1831652577

Payments from drug & device makers

$1,707in general payments, 2019–2025

Across 65 payments — averaging $26.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$265
  • Daiichi Sankyo Inc.$196
  • Johnson & Johnson$193
  • AbbVie$177
  • Novartis$142
  • Merck$86
  • plus $648 from 16 others

What the payments were for

  • Food & beverage$1,53490%
  • Education$17410%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,707 in reported general payments places this provider in the 85th percentile of 1,719 nurse practitioner providers in Arizona.

See all nurse practitioner providers in Arizona

Medicare billing

Part B allowed, 2024
$145,584
Medicare patients
77
Services billed
5,956

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban34$30,341
EliquisApixaban40$23,891
VenclextaVenetoclax11$18,644
Dexamethasone63$1,307
Ondansetron OdtOndansetron31$980
Oxycodone Hcl59$980
Doxycycline Monohydrate16$875
Hydroxyurea41$787
Anastrozole32$727
ValacyclovirValacyclovir Hcl12$725
Letrozole22$657
Acyclovir46$600
Gabapentin20$386
Tamoxifen Citrate11$334
Fluconazole12$296

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$193$30,34134 claims
PfizerEliquis$69$23,89140 claims
AbbVieVenclexta$177$18,64411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,719 nurse practitioner providers in Arizona.

Other nurse practitioner in Casa Grande

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →